Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
ctDNA or Merkel Virus Antibodies for Surveillance of Merkel Cell Carcinoma Recurrence.
Journal: JAMA dermatology
Published: July 08, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer Contraindications.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 25, 2026
Response to Wang et al., "Time as a Substantial Confounder in Evaluating Integrated Multidisciplinary Care for Advanced Cutaneous Squamous Cell Carcinoma".
Journal: Journal of the American Academy of Dermatology
Published: May 10, 2026
Discordant circulating tumor DNA results favor multiple primary malignancies in patient with synchronous Merkel cell carcinoma tumors.
Journal: JAAD case reports
Published: February 13, 2026
Bridging clinical gaps in personalized cancer neoantigen vaccines.
Journal: Cancer cell
Published: January 28, 2026
Integrated multidisciplinary care reduces time to treatment in patients with advanced cutaneous squamous cell carcinoma: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: December 11, 2025
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 02, 2025
Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable Melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 26, 2025
Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failure.
Journal: ESMO open
Published: August 30, 2025
Last Updated: 09/26/2026